E5 Pharma launches generic Proglycem
e5 Pharma is launching diazoxide oral suspension.
The product is the first generic of Teva’s Proglycem.
“We are excited to launch our first generic drug designated as a competitive generic therapy. Our mission is to provide patient access to affordable medicine. We are not looking for the next big thing; we are looking for the next great thing. Products that make all the difference in the world to people who need them, regardless of market size," e5 Pharma CEO, Bob Edwards said.